logo
  

H&M Group Sees SEK 800 Mln Restructuring Charge In Q4; To Cut Around 1,500 Jobs

Swedish retailer Hennes & Mauritz AB or H&M Group (HNNMY.PK,HMRZF.PK,HEN.L) Wednesday said it sees a restructuring charge of just over 800 million Swedish kronor in the fourth quarter related to its global cost and efficiency programme.

H&M group's global programme to reduce costs and further improve efficiency in the business, which was announced earlier, would result in workforce reductions by around 1,500 positions.

The company said the programme relates to administrative and overhead costs.

The program is estimated to provide overall annual savings of around 2 billion kronor, which are expected to become visible in the second half of 2023.

Helena Helmersson, CEO, said, "The cost and efficiency programme that we have initiated involves reviewing our organisation and we are very mindful of the fact that colleagues will be affected by this. We will support our colleagues in finding the best possible solution for their next step."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT